Literature DB >> 15769751

Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.

Laurens A van Meeteren1, Paula Ruurs, Evangelos Christodoulou, James W Goding, Hideo Takakusa, Kazuya Kikuchi, Anastassis Perrakis, Tetsuo Nagano, Wouter H Moolenaar.   

Abstract

Autotaxin (ATX) or nucleotide pyrophosphatase/phosphodiesterase 2 (NPP2) is an NPP family member that promotes tumor cell motility, experimental metastasis, and angiogenesis. ATX primarily functions as a lysophospholipase D, generating the lipid mediator lysophosphatidic acid (LPA) from lysophosphatidylcholine. ATX uses a single catalytic site for the hydrolysis of both lipid and non-lipid phosphodiesters, but its regulation is not well understood. Using a new fluorescence resonance energy transfer-based phosphodiesterase sensor that reports ATX activity with high sensitivity, we show here that ATX is potently and specifically inhibited by LPA and sphingosine 1-phosphate (S1P) in a mixed-type manner (Ki approximately 10(-7) M). The homologous ecto-phosphodiesterase NPP1, which lacks lysophospholipase D activity, is insensitive to LPA and S1P. Our results suggest that, by repressing ATX activity, LPA can regulate its own biosynthesis in the extracellular environment, and they reveal a novel role for S1P as an inhibitor of ATX, in addition to its well established role as a receptor ligand.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769751     DOI: 10.1074/jbc.M413183200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

1.  Target highlights in CASP9: Experimental target structures for the critical assessment of techniques for protein structure prediction.

Authors:  Andriy Kryshtafovych; John Moult; Sergio G Bartual; J Fernando Bazan; Helen Berman; Darren E Casteel; Evangelos Christodoulou; John K Everett; Jens Hausmann; Tatjana Heidebrecht; Tanya Hills; Raymond Hui; John F Hunt; Jayaraman Seetharaman; Andrzej Joachimiak; Michael A Kennedy; Choel Kim; Andreas Lingel; Karolina Michalska; Gaetano T Montelione; José M Otero; Anastassis Perrakis; Juan C Pizarro; Mark J van Raaij; Theresa A Ramelot; Francois Rousseau; Liang Tong; Amy K Wernimont; Jasmine Young; Torsten Schwede
Journal:  Proteins       Date:  2011-10-21

2.  Ligand-based autotaxin pharmacophore models reflect structure-based docking results.

Authors:  Catrina D Mize; Ashley M Abbott; Samantha B Gacasan; Abby L Parrill; Daniel L Baker
Journal:  J Mol Graph Model       Date:  2011-09-18       Impact factor: 2.518

Review 3.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

4.  Location, location, location: a crystal-clear view of autotaxin saturating LPA receptors.

Authors:  Adel Tabchy; Gabor Tigyi; Gordon B Mills
Journal:  Nat Struct Mol Biol       Date:  2011-02       Impact factor: 15.369

5.  Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors.

Authors:  Peng Cui; Jose L Tomsig; William F McCalmont; Sangderk Lee; Christopher J Becker; Kevin R Lynch; Timothy L Macdonald
Journal:  Bioorg Med Chem Lett       Date:  2007-01-13       Impact factor: 2.823

6.  Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts.

Authors:  Abby L Parrill; Daniel L Baker
Journal:  Expert Opin Ther Pat       Date:  2010-11-04       Impact factor: 6.674

7.  Overexpression of autotaxin is associated with human renal cell carcinoma and bladder carcinoma and their progression.

Authors:  Aihua Xu; Md Ahsanul Kabir Khan; Fangzhi Chen; Zhaohui Zhong; Han-Chun Chen; Yuanda Song
Journal:  Med Oncol       Date:  2016-10-18       Impact factor: 3.064

Review 8.  Phosphatase-resistant analogues of lysophosphatidic acid: agonists promote healing, antagonists and autotaxin inhibitors treat cancer.

Authors:  Glenn D Prestwich; Joanna Gajewiak; Honglu Zhang; Xiaoyu Xu; Guanghui Yang; Monica Serban
Journal:  Biochim Biophys Acta       Date:  2008-04-08

9.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

10.  Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.

Authors:  Lauren P Saunders; Amy Ouellette; Russ Bandle; William Chozen Chang; Hongwen Zhou; Raj N Misra; Enrique M De La Cruz; Demetrios T Braddock
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.